4th Annual Peptides Congress 2017

Over 400 peptides, proteins and antibodies attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 25 presentations and case studies focusing on the key advancements in peptides technologies, chemistry, formulation & delivery as well as peptide therapeutics

Two-day interactive conference addressing three main themes:

  • Recent Progress in Peptide Technologies & Manufacturing
  • Peptide Discovery & Development: Peptide Chemistry, Formulation & Delivery
  • Advances in Peptide Therapeutics

Co-located with the 10th Annual Proteins & Antibodies Congress

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to announce the 4th Annual Peptides Congress, taking place on 24 – 25 April 2017 in London, UK. This highly anticipated conference provides a unique opportunity for over 400 senior-level delegates to engage in scientific discussions about the current research results and latest advancements that help the industry going forward.

The peptides industry represents one of the most exciting areas of pharmaceutical research, forecasted to expand significantly over the next couple of years. The growth of the market is not only attributed to the fact that more and more pharmaceutical companies are able to share results from their peptide research projects, but also to the recent improvements in peptide synthesis technologies as well as peptide formulation & delivery. In addition to this, experts have also estimated that the global peptide therapeutics market will reach $23.7 billion by 2020.

The 2017 Peptides Congress features a revamped conference agenda that will focus on peptide technologies & manufacturing as well as peptide chemistry, formulation & delivery on Day 1. Stream 1 will feature presentations covering recent progress in peptide synthesis, advancements in peptide screening as well as CMC regulatory updates and updates in the efficient manufacturing of peptides. In Stream 2 our highly acknowledged speakers will focus on such hot topic areas as utilising macrocyclic peptides in drug discovery, novel strategies for peptide formulation and devices for the effective delivery of peptides. The areas of enhancing the immunogenicity of peptides as well as peptide analysis & quantification will also be addressed.  

Day 2 of the event will focus on peptide therapeutics. Novel case studies from exciting research areas such as infectious, respiratory and metabolic diseases and well as personalised medicine and inflammatory bowel disease (IBD) will be covered. Renowned experts will also deliver talks on peptide drug conjugates, peptide-based vaccines and immunotherapies.

The 4th Annual Peptides Congress forms part of Oxford Global’s highly successful Biologics Series. For more information on other events in this series, please see the details below:


Proteins & Antibodies, Biosimilars & Biobetters and Peptides 2016 Sponsors Included:



 

DelegateTestimonial2DelegateTestimonial3DelegateTestimonial1Solutions ProviderTestimonial5DelegateTestimonial7Solutions ProviderTestimonial4DelegateTestimonial6DelegateTestimonial4Solutions ProviderTestimonial6Solutions ProviderTestimonial3DelegateTestimonial5

Media Partners

GENMAG Small copyEPS small 2 copyOne Nucleus Small copy